Soothee Patch

Manufacturer
Better Pain Solutions, LLC
Effective date
2015-03-19
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:20:34

Label at a glance#

ProductSoothee Patch
Active ingredientLIDOCAINE, MENTHOL, CAPSAICIN, METHYL SALICYLATE
Label structure8 sections

Storage and handling

Store below 77F (25C) Avoid direct sunlight

Label contents#

Full prescribing information#

DESCRIPTION SECTION

ACTIVE INGREDIENTS:

Lidocaine   0.5%              External Analgesic

Menthol     5%                 External Analgesic/Counterirritant

Capsaicin   0.0375%        External Analgesic

Methyl Salicylate   2%     External Analgesic

INDICATIONS & USAGE SECTION

USES:

Use for temporary relief of minor aches and muscle pains associated with arthritis, simple

backache, strains, sprains, muscle soreness and stiffness

WARNINGS SECTION

WARNINGS:

  • For external use only. Use only as directed. Avoid contact with eyes and mucus membranes
  • Do not use on wounds or damaged skin
  • Stop use and ask a doctor if symptoms persist for more than seven days or clear up and occur again within a few days, or rahs, itching or excessive skin irritation occurs
  • Do not cover with bandage
  • Do no use if you are allergic to Menthol or Capsaicin
  • Consult physician for children under 12

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS:

  • Adults and children 12 years and over apply to affected area; change patch 2 to 3 times daily
  • Children under 12 years, consult a physician before use
  • How to apply:
  • Clean and dry affected area
  • Cut open pouch and remove patch
  • If desired, cut patch to size
  • Remove protective film and apply directly to area of pain
  • Apply to affected area not more than 3 times daily
  • Wash hands with soap after applying patch
  • Reseal pouch containing unused patches

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS:

Water, Glycerine, Sodium Polyacrylate, Polysorbate 80, Aloe

Barbadensis Leaf (Aloe Vera Gel) Juice, EDTA Disodium salt,

Diazolidinyl Urea, Methylparaben, Iodopropynyl Butylcabamate,

Propylparaben

STORAGE AND HANDLING SECTION

Store below 77F (25C)

Avoid direct sunlight

SPL PATIENT PACKAGE INSERT SECTION

Soothee Patch

Better-Rx Manufacturing

The potential exists for a small child or pet to suffer serious

effect from chewing or ingesting a new or used Soothee Patch,

although the risk with this formulation has not been evaluated.

It is important for pateints to store and dispose of Soothee

Patch out of the reach of children, pets and others. (See

HANDLING AND DISPOSAL)

Excessive Dosing

Excessive Dosing by applying Soothee Patch to larger areas for

longer than recommmended wearing time could result in increased absorption and higher blood concentrations. Longer

duration of application, application of more than the

recommended number of patches, smaller patients,

or impaired elimination may all contribute to increasing the blood concentration.

PRECAUTIONS

General

Allergic Reactions

Patients allergic to menthol or capsaicin or any other

ingredient in Soothee Patch should not use the Soothee Patch.

Non-intact Skin

Application tobroken or inflamed skin, although not tested,

may result in higher blood concentrations from increased absorption.

Eye Exposure

The contact of Soothee Patch with eyes, altough not studied, should be avoided

based on the findings of sever eye irritations with the use of similar products in animals.

If eye contact occurs, immediately wash out the eye with water or saline.

Pregnancy

Nursing Mothers

Soothee Patch has not been studied in nursing mothers.

Caution should be exercised when administering the Soothee

Patch to nursing mothers. When soothee patch is used concurrently with other products in the same class

Pediatric Use

Soothee Patch Safety and effectiveness has not been established in pediatric patients.

DOSAGE AND ADMINISTRATION

Apply Soothee Patch to intact skin to cover the area most

sensitive to pain. Apply up to four (4) patches per day. Each

patch should not be applied for more than 8 hours in a given

24-hour period. Patches may be cut into smaller sizes with scissors

prior to removal of the release liner. Clothing may be worn over the area of application.

Smaller areas of treatment are recommended in a debilitated patient, or patient with impaired elimination.

If irritation or a burning sensation occurs during application,

remove the patch and do not reapply until the irritation subsides. When Soothee Patch is used

concomitantly with other products containing same or similar agents, the amount

absorbed from all formulations must be considered.

HANDLING AND DISPOSAL

Hands should be washed after handling Soothee Patch, and eye contact

with Soothee Patch should be avoided. Do not store patch outside the sealed envelope.

Apply immediately after removal from the protective envelope. Fold use patches so that the adhesive

side sticks to itself and safely discard used patches or pieces of cut patches where children and pets

cannot get to them. Soothee Patch should be kept out of reach of children.

HOW SUPPLIED

Soothee Patch (Lidocaine 0.5%/Menthol 5%/Capsaicin

0.0375%/Methyl Salicylate 2%) is available as the following:

Box of 15 patches, packaged into 3 child-resistant envelopes (5

patches /envelope)

Patient Information

Soothee Patch is dispensed by prescription (Rx) under medical supervision and direction

Product Code:  69592-001-01

Better-Rx Manufacturing does not represent this product code to be a  National Drug Codes

(NDC). Product Codes are formatted according to standard industry practice, to meet the

formatting requirements of pharmacy and health insurance computer systems.

Store below 77F (25C); excursion permitted to 59-85F (15-30C) See USP Controlled Room Temperature.

Manufactured for:

Better-Rx Manufacturing

122 E Rose Lane No.C Houston Tx  77076

For questions or comments please call 1-800-311-6046

March 2015

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

copy of labelcopy of label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1728301capsaicin 0.0375 % / lidocaine 0.5 % / menthol 5 % / methyl salicylate 2 % Medicated PatchPSN1
1728301capsaicin 0.000375 MG/MG / lidocaine 0.005 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.02 MG/MG Medicated PatchSCD1
1728301capsaicin 0.0375 % / lidocaine 0.5 % / menthol 5 % / methyl salicylate 2 % Medicated PatchSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
473d070d-1c38-488e-b991-c4d1bf45aab8Product name120210201

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69592-001-012020-01-31C16284748780-19d75b9d1-0a05-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69592-001-01Soothee Patch15 in 1 BOXPATCH151
69592-001-01Soothee Patch10 g in 1 PATCHPATCH101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69592-001SOOTHEE PATCH (LIDOCAINE, MENTHOL, CAPSAICIN, METHYL SALICYLATE) PATCH [BETTER PAIN SOLUTIONS, LLC ]1Legacy NDC, 2 package rows20150320_aed1e7c1-6197-4152-ae5e-06cf2ec3020f.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CAPSAICINACTIVE INGREDIENTS07O44R1ZM1
LIDOCAINEACTIVE INGREDIENT98PI2009871
MENTHOLACTIVE INGREDIENTL7T10EIP3A1
METHYL SALICYLATEACTIVE INGREDIENTLAV5U5022Y1
CAPSAICINACTIVE MOIETYS07O44R1ZM1
LIDOCAINEACTIVE MOIETY98PI2009871
MENTHOLACTIVE MOIETYL7T10EIP3A1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0X1
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW41
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K1
GLYCERININACTIVE INGREDIENTPDC6A3C0OX1
IODOPROPYNYL BUTYLCARBAMATEINACTIVE INGREDIENT603P14DHEB1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T1
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8H1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH1
SODIUM POLYACRYLATE (2500000 MW)INACTIVE INGREDIENT05I15JNI2J1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69592-00169592-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 380 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS0.4 mgExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / TOPICAL1 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY, METERED / NASAL13 mgExact identifier — unii candidate
75 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION/ DROPS / AURICULAR (OTIC)13 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, DELAYED RELEASE / ORAL23 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION/ DROPS / OPHTHALMIC1 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, LIQUID FILLED / ORAL24 mgExact identifier — unii candidate
78 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHPOWDER, FOR SUSPENSION / ORAL8 mgExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / OPHTHALMIC4 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TOINTMENT / TOPICAL29 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / NASAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KGEL / VAGINAL5 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM, AUGMENTED / TOPICAL2 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SOLUTION / EPIDURAL30 mgExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / TOPICAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION / INTRAVENOUS4680 mgExact identifier — unii candidate
78 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET, EXTENDED RELEASE / ORAL0.12 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS0.8 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCONCENTRATE / ORAL12 mgExact identifier — unii candidate
79 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET / ORAL100 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRADERMAL1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / INTRAMUSCULAR0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSYSTEM / TOPICAL126 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION/ DROPS / OPHTHALMIC2.5 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE / ORAL418.37 mgExact identifier — unii candidate
78 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / PERINEURAL80 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / INTRAVENOUS6 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRAMUSCULAR450 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TDROPS / ORAL1 mg/1mlExact identifier — unii candidate
79 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSYSTEM / IONTOPHORESIS0.1 mgExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / ORAL100 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / SOFT TISSUE0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SOLUTION / PARENTERAL30 mgExact identifier — unii candidate
79 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KGEL / OPHTHALMIC396 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET, CHEWABLE / ORAL1.28 mgExact identifier — unii candidate
79 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRAVITREAL0.02 %w/vExact identifier — unii candidate
78 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TELIXIR / ORAL800 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPASTE, DENTIFRICE / DENTAL0.05 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / RESPIRATORY (INHALATION)1 mgExact identifier — unii candidate
78 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / VAGINAL227.9 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KGEL / TRANSDERMAL1 mgExact identifier — unii candidate
77 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HEMULSION / OPHTHALMIC26 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUPPOSITORY / RECTAL72.15 mgExact identifier — unii candidate
78 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHDROPS / AURICULAR (OTIC)NAExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET / ORAL1.8 mgExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / AURICULAR (OTIC)63.64 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRACARDIAC2 mgExact identifier — unii candidate
77 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HAEROSOL, FOAM / VAGINAL3 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HLIQUID / INTRAVENOUS720 mgExact identifier — unii candidate
78 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSUSPENSION / OPHTHALMIC0.06 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / DENTAL15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSUSPENSION/ DROPS / OPHTHALMIC1 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / NASAL25 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRAVENOUS10 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / AURICULAR (OTIC)1 %w/vExact identifier — unii candidate
78 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLOTION / TOPICAL3990 mgExact identifier — unii candidate
75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4fef7bc1-f035-46bd-b46f-b4d305f614e7aed1e7c1-6197-4152-ae5e-06cf2ec3020f2015-03-19WarningsExact identifier
spl id: 4fef7bc1-f035-46bd-b46f-b4d305f614e7
spl set id: aed1e7c1-6197-4152-ae5e-06cf2ec3020f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.